Drug class
Non-nucleoside reverse transcriptase inhibitor (NNRTI); antiretroviral
Mechanism of action
Directly binds HIV-1 reverse transcriptase at an allosteric site, inhibiting RNA- and DNA-dependent DNA polymerase activity and preventing viral replication.
General use cases
- Treatment of HIV-1 infection in adults and eligible adolescents as part of combination antiretroviral therapy, in patients without known resistance-associated substitutions to doravirine; not used as monotherapy
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
